liveBook · Manning

Design-make-test-analyze cycle

As explained in Build AI Drug Discovery Pipelines

A design-make-test-learn cycle is an iterative drug-discovery workflow that designs compounds, synthesizes them, tests them experimentally, and learns from the results.

The design-make-test-learn cycle is a closed-loop drug-discovery workflow: models select compounds for synthesis and testing, experimental results update the models, and the process repeats. section 13.2.3

The cycle connects four practical stages:

  • Design candidates using predictions, ensemble models, and acquisition functions that balance expected value with uncertainty. section 13.2.3
  • Make prioritized compounds through experimental or robotic synthesis. section 13.2.3
  • Test compounds experimentally instead of screening an entire library indiscriminately. section 13.2.3
  • Learn by feeding measurements back into the models and selecting the next experiment. section 13.2.3

Industrial-scale cycle

Exscientia's Centaur Chemist combines acquisition functions with continuous robotic synthesis on a two-to-three-week cycle; four to eight cycles synthesize 350–500 compounds rather than 2,500 or more. section 13.2.3

Early cycles may favor diverse selection because too little labeled data makes predictions and uncertainty estimates unreliable. Fixed libraries also limit discovery of novel chemotypes. section 13.2.3

How Build AI Drug Discovery Pipelines covers it

How deep it goes
Explains the closed-loop integration pattern, acquisition tradeoffs, industrial cadence, and cold-start and novelty failure modes.
Examples
Uses robotic synthesis, Exscientia's Centaur Chemist, two-to-three-week cycles, and 350–500 versus 2,500-plus compounds.
What you can do after
Apply it via active learning to prioritize experiments, update predictive models, and iterate toward better drug candidates.
How it connects
Connects active learning, surrogate models, ensemble prediction, acquisition functions, uncertainty estimation, and generative models.

This explainer was generated by Manning's knowledge graph from the text of Build AI Drug Discovery Pipelines. The section links point to the parts of the book it draws on.